Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

413
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
413
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

307
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
307
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

1.6K
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
1.6K
Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

3.4K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
3.4K
Obesity01:24

Obesity

1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

1.8K
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex Differences in Incidence and Risk Factors for Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Propensity Score-Matched Analysis.

Journal of the American Heart Association·2025
Same author

Introducing an index on prediction of post-revascularization cerebral infarction using preoperative CT perfusion parameters in moyamoya disease.

Insights into imaging·2025
Same author

Clinical Effectiveness of Automated Coronary CT-derived Fractional Flow Reserve: A Chinese Randomized Controlled Trial.

Radiology·2024
Same author

Short-Term Changes in Weight, Body Composition, and Metabolic Biomarkers After Laparoscopic Sleeve Gastrectomy in Patients with Obesity: A Comparative Prospective Study.

Obesity surgery·2024
Same author

Early and delayed blood-brain barrier permeability predicts delayed cerebral ischemia and outcomes following aneurysmal subarachnoid hemorrhage.

European radiology·2024
Same author

[Risk factors on the unintentional injuries among rural children aged 0-12 in Shaanxi province].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2013

Related Experiment Video

Updated: Apr 16, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

7.6K

Metabolic Syndrome Modifies Changes in Body Composition After Sleeve Gastrectomy: A Quantitative CT Study.

Rui-Jia Yan1, Chao Zhang1, Min-Hong Wang1

  • 1Department of Radiology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, 241001, People's Republic of China.

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|April 15, 2026
PubMed
Summary

Laparoscopic sleeve gastrectomy (LSG) improves body composition and metabolic health in obese patients. Metabolic status influences how body composition changes correlate with lab results post-surgery.

Keywords:
CTbariatric surgerymetabolic syndromeobesity

More Related Videos

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.9K
A Murine Model of Vertical Sleeve Gastrectomy
06:47

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

12.0K

Related Experiment Videos

Last Updated: Apr 16, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

7.6K
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.9K
A Murine Model of Vertical Sleeve Gastrectomy
06:47

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

12.0K

Area of Science:

  • Bariatric Surgery Outcomes
  • Metabolic Health and Obesity
  • Body Composition Analysis

Background:

  • Obesity is a complex metabolic disorder associated with significant health risks.
  • Laparoscopic sleeve gastrectomy (LSG) is a common bariatric procedure for weight loss.
  • The impact of LSG on body composition and metabolic parameters can vary based on individual metabolic status, such as the presence of metabolic syndrome (MS).

Purpose of the Study:

  • To evaluate changes in body mass index (BMI), body composition, and laboratory markers after LSG.
  • To compare these changes between obese patients with and without metabolic syndrome (MS).
  • To analyze the correlations between body composition and clinical indicators, stratified by MS status.

Main Methods:

  • Prospective study of 52 obese patients undergoing LSG.
  • Collection of clinical and CT-based body composition data preoperatively and at 12-month follow-up.
  • Categorization into metabolic syndrome (MS) and non-MS groups for comparative analysis.

Main Results:

  • All patients showed significant improvements in weight, laboratory parameters, and body composition post-LSG.
  • Visceral fat area and liver fat (LF) demonstrated the most substantial improvements.
  • Greater reductions in BMI and postvertebral muscle fat were observed in the non-MS group. Postoperative changes in LF correlated with blood glucose in the MS group, while BMI changes correlated with triglycerides and LDL in the non-MS group.

Conclusions:

  • LSG effectively improves body composition and metabolic parameters in obese individuals.
  • The relationship between body composition changes and laboratory indicators post-LSG is dependent on the patient's metabolic status.
  • Tailored interventions based on comprehensive body composition and metabolic assessments are crucial for optimizing outcomes in bariatric surgery patients with distinct metabolic phenotypes.